Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [41] Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
    Barrett, Aisling
    Quinn, John
    Lavin, Michelle
    Thornton, Patrick
    O'Donnell, James
    Murphy, Philip
    Glavey, Siobhan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [42] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
    Joanna Rupa-Matysek
    Lidia Gil
    Maciej Kaźmierczak
    Marta Barańska
    Mieczysław Komarnicki
    Medical Oncology, 2018, 35
  • [43] The performance of Khorana risk score for prediction of venous thromboembolism in patients with lung cancer: A retrospective cohort study
    Kizilirmak, Deniz
    Fidan, Ugur
    Havlucu, Yavuz
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (02): : 114 - 119
  • [44] The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry
    Prandoni, Paolo
    Bilora, Franca
    Mahe, Isabelle
    Varona, Jose. F.
    Pedrajas, Jose Maria
    Meireles, Jose
    Pesavento, Raffaele
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2023, 224 : 17 - 20
  • [45] Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal
    Legnani, Cristina
    Mattarozzi, Silvia
    Cini, Michela
    Cosmi, Benilde
    Favaretto, Elisabetta
    Palareti, Gualtiero
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 227 - 232
  • [46] A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer
    Cohen, Alexander T.
    Wallenhorst, Christopher
    Choudhuri, Satarupa
    Nassar, Ayman
    Pollock, Kevin G.
    Martinez, Carlos
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (04) : 324 - 336
  • [47] Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
    Alonso, Alvaro
    Norby, Faye L.
    MacLehose, Richard F.
    Zakai, Neil A.
    Walker, Rob F.
    Adam, Terrence J.
    Lutsey, Pamela L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (18):
  • [48] Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation
    Ensor, Joie
    Riley, Richard D.
    Jowett, Sue
    Monahan, Mark
    Snell, Kym I. E.
    Bayliss, Susan
    Moore, David
    Fitzmaurice, David
    HEALTH TECHNOLOGY ASSESSMENT, 2016, 20 (12) : 1 - +
  • [49] Risk of recurrence after transient inflammation-associated venous thromboembolism: similar to provoked, unprovoked or in-between?
    Bhoelan, Bibie Soerajja
    Borjas Howard, Jaime F.
    Tichelaar, Ynse Ieuwe Gerardus Vladimir
    Meijer, Karina
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : e343 - e346
  • [50] A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
    Barbar, S.
    Noventa, F.
    Rossetto, V.
    Ferrari, A.
    Brandolin, B.
    Perlati, M.
    De Bon, E.
    Tormene, D.
    Pagnan, A.
    Prandoni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) : 2450 - 2457